Navigation Links
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
Date:8/4/2009

SAN CARLOS, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2009.

Net loss for the quarter ended June 30, 2009 was $32.1 million or $0.35 per share, compared to net loss of $33.4 million or $0.36 per share in the second quarter of 2008.

Nektar made improvements to its operating efficiencies as compared to a year ago. Total operating costs and expenses were down 19% to $43.5 million in the second quarter of 2009 as compared to $53.8 million in the second quarter of 2008. For the first half of 2009, total operating costs and expenses were down 28% to $83.5 million as compared to $115.6 million in the first half of 2008.

"In the first half of 2009, we made a strong commitment to advancing our clinical pipeline," stated Howard W. Robin, President and Chief Executive Officer of Nektar. "We completed our Phase 2 clinical program for NKTR-118, and we are poised to report Phase 2 data for NKTR-102 and Phase 1 data for NKTR-105 by year-end. These achievements underscore the strength of Nektar's drug development organization and our successful strategy to focus on developing proprietary drugs with our advanced polymer conjugate technology."

Research and development expense was $24.2 million in the second quarter of 2009 as compared to $33.5 million for the same quarter in 2008. For the first half of 2009, research and development expense was $48.0 million as compared to $70.9 million for the first half of 2008. Included in the $48.0 million of overall research and development expense in the first half of 2009 is approximately $27.4 million of investment in Nektar preclinical and clinical development programs.

Revenue for the three month period ende
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 ISPE , the ... has released a preview of its Drug Shortages ... avoid drug shortages and maintain a robust and reliable ... The Plan, a first for the industry, was developed ... members and describes how industry can best prevent drug ...
(Date:8/27/2014)... Aug. 27, 2014 Pulse Systems, Inc. , ... Practice Management , and Revenue Cycle Management (RCM) ... practices performed by some RCM vendors, at UBM Medica,s ... on September 19-20, 2014.  A presenter ... in September with a new session encouraging practices to "Look ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Animal ... About Animal Health Animal health ... diseases or treat animals to enhance their quality ... yield of animal food. The Global Animal Health ...
Breaking Medicine Technology:ISPE Releases First Look at its Plan to Prevent Drug Shortages 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 3ISPE Releases First Look at its Plan to Prevent Drug Shortages 4Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7
... Calif., March 15, 2012  With the economic crisis and ... unprecedented challenges. To flourish, clinics now will need to ... To facilitate this change in strategy, the California HealthCare ... announces the California Catalyst Fund , designed to ...
... March 15, 2012  Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical ... stem cells (CSCs) and tumor bulk, today announced that ... Since serving as Chief Executive Officer of Cephalon, ... Industries (Nasdaq: TEVA ) in October 2011, ...
Cached Medicine Technology:New Restructuring Fund Launches for California Community Clinics 2Stemline Therapeutics Appoints Kevin Buchi, Former CEO of Cephalon, to Its Board of Directors 2
(Date:8/27/2014)... Recently, UWDress.com, a popular supplier of wedding dresses ... new range of elegant bridesmaid dresses . There ... All the company's new and old customers can get ... , This experienced company focuses on affordable clothes ... bridal gowns, backless party outfits, princess wedding gowns and ...
(Date:8/27/2014)... Diego, CA (PRWEB) August 27, 2014 ... insurance policies will now be easier for the public ... insurance prices that are promoted in all 50 states ... . , The different insurers that are generating ... made it possible for adults to use the programmed ...
(Date:8/27/2014)... The New York Mobility Club (sponsored by ... about “ Sexuality & Intimacy ” for people with ... entertaining discussions are for mature audiences only. September 9 ... Mamaroneck, NY) and October 7 from 6-8 pm at ... The New York Mobility Club is a local community ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s running apparel brand is ... most noted for her brave running of the 1967 all-male ... running clothes that unites the history of women’s competitive running ... , “It is such an honor to work with ... the original Skirt – she stood strong, pushing herself to ...
(Date:8/27/2014)... 2014 Seventy-three members of the founding ... the beginning of their careers as healthcare professionals at ... Students entering a four-year PharmD program traditionally receive white ... them into the profession as colleagues dedicated to patient ... the Garrison Theater in Claremont, Calif., KGI President Sheldon ...
Breaking Medicine News(10 mins):Health News:Elegant Bridesmaid Dresses For 2014 Now Available At UWDress.com 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2
... -- The U.S. Food and Drug Administration says it has ... commonly known as Avastin, is being sold in the United ... which the FDA says contains no active ingredient -- is ... medication that is approved for use in Turkey but not ...
... 4 (HealthDay News) -- There appears to be a ... best known as Depo-Provera, and an increased risk of ... For the study, researchers compared more than 1,000 Seattle-area ... breast cancer, and more than 900 women without breast ...
... YORK, APRIL 4, 2012 A new study offers ... lethal damage to the gastrointestinal (GI) tract caused by ... those occurring during a nuclear incident. There are currently ... condition, known as radiation gastrointestinal syndrome (RGS), which is ...
... scientists, engineers and physicians from Brigham and Women,s ... School (HMS), Massachusetts Institute of Technology (MIT), BIND ... University Karmanos Cancer Institute, and Weill Cornell Medical ... targeted cancer drug called BIND-014 in treating solid ...
... (HealthDay News) -- Really, really liking yourself may give ... new study suggests. That,s because narcissists, known to ... talk about and promote themselves, which projects confidence and ... In their two-part study, narcissists scored much higher in ...
... MA (April 4, 2012)-- IntegraGen, Inc., a biotechnology company ... of the ARISk Risk Assessment Test, a gender specific, ... associated with Autism Spectrum Disorder (ASD). The test is ... from multiplex familiessiblings of children with ASD who are ...
Cached Medicine News:Health News:More Fake Avastin Found in U.S., FDA Says 2Health News:Depo-Provera Birth Control Might Raise Breast Cancer Risk 2Health News:Antibody therapy prevents gastrointestinal damage following radiation exposure in mice 2Health News:First targeted nanomedicine to enter human clinical studies 2Health News:First targeted nanomedicine to enter human clinical studies 3Health News:First targeted nanomedicine to enter human clinical studies 4Health News:Narcissists Often Ace Job Interviews, Study Finds 2Health News:IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children 2Health News:IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: